ELV Q3 2020 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q3 2020 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$31.2B+16.8% YoY

Gross Profit

$8.2B26.4% margin

Operating Income

$617M2.0% margin

Net Income

$222M0.7% margin

EPS (Diluted)

$0.87

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

-$1.1B

Free Cash Flow

-$1.5B

Stock-Based Comp.

$80M

Balance Sheet

Total Assets

$86.6B

Total Liabilities

$52.7B

Stockholders' Equity

$33.9B

Cash & Equivalents

$4.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31.2B	$26.7B	+16.8%
Gross Profit	$8.2B	$5.9B	+39.1%
Operating Income	$617M	$1.7B	-63.1%
Net Income	$222M	$1.2B	-81.2%

Revenue Segments

Government Business Segment

$18.1B52%

Commercial Specialty Business Segment

$9.3B27%

IngenioRx Segment

$5.6B16%

Other Segment

$1.8B5%